Stoke Therapeutics (NasdaqGS:STOK) FY Conference September 09, 2026 01:00 PM ET Company ParticipantsPete Stavropoulos - Director of Biotech Equity ResearchIan F. Smith - CEOJason Hoitt - Chief Patient OfficerPete StavropoulosHello. Welcome to the Cantor Global Healthcare Conference. I'm Pete Stavropoulos, a biotech analyst with Cantor. With us, we have Stoke Therapeutics, a company I cover. I'm pleased to introduce Ian F. Smith, CEO, and Jason Hoitt, the Chief Patient Officer. With that, start off with a br ...